Associate Professor, Preventive Medicine & Public
Dr. Richter’s research is focused on understanding and treating tobacco dependence, as well as training health professionals to incorporate tobacco treatment into their clinical practice. She is clinical director of the University of Kansas Hospital’s highly successful tobacco treatment program, UKanQuit at KUMed. Specific National Institutes of Health (NIH) research projects include evaluating the effectiveness and cost-effectiveness of video versus phone counseling for delivering cessation services to rural smokers, comparing fax to phone transfer for linking hospitalized smokers with cessation services after discharge, and clinic-level studies of tobacco treatment practices in drug treatment facilities.
In collaboration with Dr. Paula Cupertino, Dr. Richter leads an NIH Fogarty Center project designed to build capacity for research and better understand tobacco treatment practices in Brazil. She also serves as co-investigator on NIH-funded studies addressing motivating smokers to quit and developing specialized care for smokers in methadone treatment. She is President of the Association for Medical Education and Research on Substance Abuse (AMERSA); serves on the editorial board of the journals Addiction Science and Clinical Practice and Current Drug Abuse Reviews; is a founding commissioner of the Council for Tobacco Treatment Training Programs, which accredits tobacco treatment training programs; and is a member of the NIH study section Community Level Health Promotion. She mentors and advises graduate students and junior faculty. In addition, she teaches a core course for the MPH concentration in Health Policy and Management, Financial and Human Resource Management.